Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SAVA | US
-0.56
-5.15%
Healthcare
Biotechnology
31/03/2024
05/07/2024
10.21
10.83
11.13
10.00
Cassava Sciences Inc. a clinical stage biotechnology company develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam a small molecule drug which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics Inc. and changed its name to Cassava Sciences Inc. in March 2019. The company was incorporated in 1998 and is based in Austin Texas.
View LessNegative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
168.3%1 month
124.0%3 months
99.4%6 months
80.4%-
34.01
7.16
-
-
-8.26
-
-
-97.93M
490.08M
490.08M
-
-
-
-
-33.90
18.97
28.13
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
11.71
Range1M
12.56
Range3M
17.89
Rel. volume
1.19
Price X volume
27.38M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | CRBP | Biotechnology | 50.31 | 537.65M | 1.31% | n/a | 17.83% |
Oculis Holding AG Ordinary shares | OCS | Biotechnology | 11.66 | 537.00M | -0.55% | 65.83 | 0.75% |
REGENXBIO Inc | RGNX | Biotechnology | 10.9 | 536.89M | 0.74% | n/a | 43.66% |
PureTech Health plc | PRTC | Biotechnology | 22.03 | 527.22M | -4.67% | n/a | 5.50% |
Adeptus Health Inc | ADPT | Biotechnology | 3.54 | 521.68M | 4.42% | n/a | 35.10% |
ORIC Pharmaceuticals Inc | ORIC | Biotechnology | 7.69 | 518.48M | 2.26% | n/a | 0.84% |
Applied Therapeutics Inc | APLT | Biotechnology | 4.51 | 515.34M | 2.97% | n/a | 0.51% |
Mind Medicine (MindMed) Inc. Subordinate Voting Shares | MNMD | Biotechnology | 7.08 | 508.86M | -0.84% | n/a | 7.24% |
ITOS | ITOS | Biotechnology | 14.015 | 506.26M | -5.18% | n/a | 1.08% |
ATXS | ATXS | Biotechnology | 9.08 | 498.61M | 0.89% | n/a | 0.05% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.36 | 324.63M | -2.40% | 10.10 | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 2.74 | 316.67M | -3.52% | 75.75 | 80.81% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.55 | 298.02M | -0.34% | 8.24 | 25.57% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 26.52 | 294.97M | -4.29% | 17.47 | -562.47% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 12.93 | 209.56M | -2.78% | 8.94 | 15.44% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 44.59 | 128.20M | -4.23% | 7.40 | 89.91% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.955 | 93.67M | -3.08% | 13.70 | 4.17% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -8.26 | -2.43 | Cheaper |
Ent. to Revenue | - | 4,101.76 | - |
PE Ratio | - | 41.26 | - |
Price to Book | 7.16 | 22.34 | Cheaper |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 99.38 | 76.52 | Riskier |
Debt to Equity | - | 0.51 | - |
Debt to Assets | - | 0.24 | - |
Market Cap | 490.08M | 3.77B | Emerging |